The change and clinical significance of the serum uric acid levels in patients with lupus nephritis

WANG Yi-ya; WU Yong-gui

doi:10.3969/j.issn.1671-2390.2017.12.002

Journal of Clinical Nephrology > 2017 > 17(12): 716-720. > DOI: 10.3969/j.issn.1671-2390.2017.12.002

WANG Yi-ya, WU Yong-gui. The change and clinical significance of the serum uric acid levels in patients with lupus nephritis[J]. Journal of Clinical Nephrology, 2017, 17(12): 716-720. DOI: 10.3969/j.issn.1671-2390.2017.12.002

Citation:

PDF (506 KB)

The change and clinical significance of the serum uric acid levels in patients with lupus nephritis

WANG Yi-ya,
WU Yong-gui^,

Department of Nephrology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China

More Information

Received Date: August 29, 2017
Rev Recd Date: November 20, 2017
Available Online: May 11, 2023
Published Date: December 27, 2017

Graphical Abstract

Abstract

Abstract

Objective To observe the serum uric acid levels in patients with lupus nephritis (LN) and explore its relationship with renal damage. Methods A retrospective analysis of the data of 110 cases for nephrology renal biopsy and diagnosis of LN patients was made in the First Affiliated Hospital of Medical University of Anhui from January July 2015 to July 2017. The patients were divided into the two groups:LN patients with or without hypemricemia.All patients were collected for clinical pathological indicators, including age, gender, serum creatinine, urea nitrogen, serum uric acid, complement C3, complement C4, immunoglobulin A, immunoglobulin M, immunoglobulin G, 24-h urine protein, anti-double-stranded DNA, -Smith, -SSA, -SSB, -RNP antibodies and pathological types,and scored for activity index, chronic index and systemic lupus erythematosus disease activity index. Results The clinical indicators, including the incidence rate of hypertension, level of blood serum creatinine and urea nitrogen, and the renal pathological scores, including acitive index and chronic index, in the LN patients with hyperuricemia group were higher than that in normal uric acid group, and estimate glomerular filtration rate was lower than that in normal uric acid group, the difference was statistically significant(P<0.05). However, there was no significant difference between the two groups in the other factors such as age, sex, complement C3, complement C4, immunoglobulin A, immunoglobulin M, immunoglobulin G, 24-h urine protein, systemic lupus erythematosus disease activity index score and positive rate of anti-double-stranded DNA, -Smith, -SSA, -SSB,-RNP antibodies (P>0.05). Further analysis showed that the level of serum uric acid was positively correlated with serum creatinine, renal pathological classification and renal pathological scores, negatively correlate with estimate glomerular filtration rate(P<0.05). Conclusions LN patients with hyperuricemia had more severe renal damage than those in normal uric acid. Hyperuricemia is an important indicator for poor prognosis in patients with LN.
- Uric acid,
- Lupus nephritis,
- Renal damage

FullText(HTML)

References (23)

References

[1]	Fortuna G, Brennan MT. Systemic lupus erythematosus:epidemiology, pathophysiology, manifestations, and management[J]. Dent Clin North Am, 2013, 57(4):631-655.
[2]	李娜, 李宝全, 巩路. 抗C1q抗体在系统性红斑狼疮及狼疮性肾炎诊断中的作用[J]. 天津医科大学学报, 2011, 17(4):546-548.
[3]	Koutsokeras T, Healy T. Systemic lupus erythematosus and lupus nephritis[J]. Nat Rev Drug Discov, 2014, 13(3):173-174.
[4]	Chan TM. Treatment of severe lupus nephritis:the new horizon[J]. Nat Rev Nephrol, 2015, 11(1):46-61.
[5]	Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease[J]. J Am Soc Nephrol, 2002, 13(12):2888-2897.
[6]	Yang Z, Liang Y, Xi W, et al. Association of serum uric acid with lupus nephritis in systemic lupus erythematosus[J]. Rheumatol Int, 2011, 31(6):743-748.
[7]	Xie T, Chen M, Tang X, et al. Hyperuricemia is an independent risk factor for renal pathological damage and poor prognosis in lupus nephritis patients[J]. Zhong Nan Da Xue Bao Yi Xue Ban, 2016, 41(10):1052-1057.
[8]	Stevens LA, Coresh J, Feldman HI, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population[J]. J Am Soc Nephrol, 2007, 18(10):2749-2757.
[9]	Kang DH, Nakagawa T. Uric acid and chronic renal disease:possible implication of hyperuricemia on progression of renal disease[J]. Semin Nephrol, 2005, 25(1):43-49.
[10]	Khosla UM, Zharikoy S, Finch JL, et al. Hyperuricemiainduces endothelial dysfunction[J]. Kidney Int, 2015, 67(5):1739.
[11]	Kim SM, Lee SH, Kim YG, et al. Hyperuricemia-induced NLRP3 activation of macronphages contributes to the progression of diabetic nephropathy[J]. Am J Physiol Renal Physiol, 2015, 308(9):F993-F1003.
[12]	Kirac Y, Bilen S, Duranay M. Comparison of laboratory findings in patients with glomerulonephritis classified according to bistopathologic diagnosis[J]. Minerva Med, 2014, 105(2):149-156.
[13]	Mallat SG, Al Kattar S, Tanios BY, et al. Hyperuricemia, hypertension, and chronic kidney disease:an emerging association[J]. Curr Hypertens rep, 2016, 18(10):74.
[14]	Qu LH, Jiang H, Chen JH. Effect of uric acid-lowering therapy on blood pressure:systematic review and meta-analysis[J]. Ann Med, 2017, 49(2):142-156.
[15]	Long CL, Qin XC, Pan ZY, et al. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia[J]. J Hypertens, 2008, 26(12):2326-2338.
[16]	Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism[J]. Hypertension, 2001, 38(5):1101-1106.
[17]	Zharikov S, Krotova K, Hu H, et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells[J]. Am J Physiol Cell Physiol, 2008, 295(5):C1183-C1190.
[18]	Chao HH, Liu JC, Lin JW, et al. Uric acid stimulates endothelin-1 gene expression associated with NADPH oxidase in human aortic smooth muscle cells[J]. Acta Pharmacol Sin, 2008, 29(11):1301-1312.
[19]	刘琳. 肾脏管球反馈在高尿酸诱导高血压发病中可能的机制[D]. 北京:北京协和医学院, 2013.
[20]	付豆, 丁国华, 王惠明, 等. 血尿酸水平与系统性红斑狼疮活动度及其肾损害的关系[J]. 山东医学, 2017, 57(5):43-45.
[21]	Levy GD, Rashid N, Niu F, et al. Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia[J]. J Rheumatol, 2014, 41(5):955-962.
[22]	Madero M, Sarnak MJ, Wang X, et al. Uric acid and long-term outcomes in CKD[J]. Am J Kidney Dis, 2009, 53(5):796-803.
[23]	Yang J, Liang D, Zhang H, et al. Long-term renal outcomes in a cohort of 1814 Chinese patients with biopsy-proven lupus nephritis[J]. Lupus, 2015, 24(14):1468-1478.

Cited By

Get Citation

PDF

XML

Article views (369) PDF downloads (338)

Turn off MathJax

Article Contents

Abstract

References

The change and clinical significance of the serum uric acid levels in patients with lupus nephritis

Abstract

References

Catalog

Export File

Citation

Format

Content